Schizophrenia Research
Volume 106, Issue 2 , Pages 294-299 , December 2008

Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia

  • Matthew J. Smith

      Affiliations

    • Northwestern University, Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, United States
    • Corresponding Author InformationCorresponding authors. Northwestern University, Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, 446 East Ontario Street, Suite 7-100, Chicago, IL 60611, United States. Tel.: +1 312 695 8173; fax: +1 312 695 6276.
    web address
    • ,
  • Deanna M. Barch

      Affiliations

    • Washington University, Department of Psychiatry, United States
    • Washington University, Department of Psychology, United States
    • Washington University, Department of Radiology, United States
    • Washington University, Conte Center for the Neuroscience of Mental Disorders, United States
    • ,
  • Timothy J. Wolf

      Affiliations

    • Washington University, Program in Occupational Therapy, United States
    • ,
  • Daniel Mamah

      Affiliations

    • Washington University, Department of Psychiatry, United States
    • Washington University, Conte Center for the Neuroscience of Mental Disorders, United States
    • ,
  • John G. Csernansky

      Affiliations

    • Northwestern University, Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, United States

Received 8 April 2008 ,Revised 21 July 2008 ,Accepted 28 July 2008.

References 

  1. Beratis S, Katrivanou A, Gourzis P. Factors affecting smoking in schizophrenia. Compr. Psychiatry. 2001;42:393–402
  2. Brown SA, Goldman MS, Inn A, Anderson LR. Expectations of reinforcement from alcohol: their domain and relation to drinking patterns. J. Consult. Clin. Psychol. 1980;48:419–426
  3. Buckley PF. Substance abuse in schizophrenia: a review. J. Clin. Psychiatry. 1998;59:26–30
  4. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance use comorbidity in schizophrenia. Biol. Psychiatry. 2001;50:71–83
  5. Clementz BA, Sweeney JA. Is eye movement dysfunction a biological marker for schizophrenia? A methodological review. Psychol. Bull. 1990;108:77–92
  6. Compton WM, Thomas YF, Stinson F, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry. 2007;64:566–576
  7. Cooper ML, Russell M, George WH. Coping, expectancies, and alcohol abuse: a test of social learning formulations. J. Abnorm. Psychol. 1988;97:218–230
  8. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev. Med. 2004;38:613–619
  9. de Leon J, Tracy J, McCann E, McGrory A, Diaz FJ. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr. Res. 2002;56:55–65
  10. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry. 1991;148:224–230
  11. First MB, Spitzer RL, Miriam G, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002;
  12. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI, Maxwell ME, Schreiber J, et al. A controlled family study of chronic psychoses: schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry. 1988;45:328–336
  13. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry. 2003;160:636–645
  14. Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352:1611–1616
  15. Harford TC, Grant BF, Yi H, Chen CM. Patterns of DSM-IV alcohol abuse and dependence criteria among adolescents and adults: results from the 2001 National Household Survey on Drug Abuse. Alcohol., Clin. Exp. Res. 2005;29:810–828
  16. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony J. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry. 1997;54:313–321
  17. Lyons MJ, Bar JL, Kremen WS, Toomey R, Eisen SA, Goldberg J, et al. Nicotine and familial vulnerability to schizophrenia: a discordant twin study. J. Abnorm. Psychol. 2002;111:687–693
  18. Lysaker P, Bell M, Beam-Goulet J, Milstein R. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J. Nerv. Mental Dis. 1994;182:109–112
  19. Marlatt GA, Kosturn CF, Lang AR. Provocation to anger and opportunity for retaliation as determinants of alcohol consumption in social drinkers. J. Abnorm. Psychol. 1975;84:652–659
  20. Martin LF, Freedman R. Schizophrenia and the α7 nicotinic acetylcholine receptor. Int. Rev. Neurobiol. 2007;78:225–246
  21. McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case–control study. Br. J. Psychiatry. 2002;181:321–325
  22. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 1990;16:31–56
  23. Mulford H. Stress, alcohol intake and problem drinking in Iowa. In:  Pohorecky LA,  Brick J editor. Stress and Alcohol Use, proceedings of the First International Symposium on Stress and Alcohol Use. New York: Elsevier; 1983;p. (pp. 321–332)
  24. Rehm J, Gmel G, Sepos CT, Trevisan M. Alcohol-related morbidity and mortality. Alcohol Res. Health. 2003;27:39–51
  25. Revell AD, Warburton DM, Wesnes K. Smoking as a coping strategy. Addict. Behav. 1985;10:209–224
  26. Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, et al. Health habits of patients with schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 2007;42:268–2716
  27. Sanap M, Chapman MJ. Severe ethanol poisoning: a case report and brief review. Crit. Care Resusc. 2003;5:106–108
  28. Skinner HA. Development and validation of a Lifetime Alcohol Consumption Assessment Procedure. Toronto, Canada: Addiction Research Foundation; 1982;
  29. Smith MJ, Greenberg JS. Factors contributing to the quality of sibling relationships for adults with schizoiphrenia. Psychiatr. Serv. 2008;59:57–62
  30. Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology. 2002;27:479–497
  31. Sullivan EV, Rosenbloom MJ, Lim KO, Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structures. Neuropsychology. 2000;14:178–188
  32. Varma SL, Sharma I. Psychiatric morbidity in the first-degree relatives of schizophrenia patients. Br. J. Psychiatry. 1993;162:672–678
  33. U.S. Department of Health and Human Services , Centers for Disease Control and Prevention . The health consequences of smoking: a report of the surgeon general. Washington, D.C: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004;
  34. U.S. Department of Health and Human Services , Center for Disease Control and Prevention . Cigarette smoking among adults—United States, 2004. Morb. Mortal. Wkly. Rep. 2005;54:1121–1124
  35. U.S. Department of Health and Human Services , Centers for Disease Control and Prevention . Health behaviors of adults: United States, 2002–04. Vital Health Stat. 2006;10:230
  36. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am. J. Epidemiol. 2002;156:319–327

PII: S0920-9964(08)00339-3

doi: 10.1016/j.schres.2008.07.015

Schizophrenia Research
Volume 106, Issue 2 , Pages 294-299 , December 2008

Article Tools